Evidence map›Paper›PMID 38262408›Full record

ArticleCell2024

DNA-guided transcription factor cooperativity shapes face and limb mesenchyme.

Seungsoo Kim, Ekaterina Morgunova, Sahin Naqvi, Seppe Goovaerts, Maram Bader, Mervenaz Koska, Alexander Popov, Christy Luong, Angela Pogson, Tomek Swigut and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Nonlinearities and Switch-Like Behavior in Gene Expression: From Genetics to Biochemistry and Back.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Predictive design of tissue-specific mammalian enhancers that functionbioRxiv : the preprint server for biology · 2025
    Article
  18. Article
  19. Article
  20. Enhancer Reprogramming Reveals the Tumorigenic Role of PTPRZ1 in Lung Squamous Cell Carcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 6 countries.

Seungsoo KimDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford, CA 94305, USA.
Ekaterina MorgunovaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden.
Sahin NaqviDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Department of Genetics, Stanford University, Stanford, CA 94305, USA.
Seppe GoovaertsMedical Imaging Research Center, UZ Leuven, Leuven, Belgium; Department of Human Genetics, KU Leuven, Leuven, Belgium.
Maram BaderDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA.
Mervenaz KoskaDepartment of Developmental Biology, Stanford University, Stanford, CA 94305, USA.
Alexander PopovEuropean Synchrotron Radiation Facility, Grenoble, France.
Christy LuongDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA.
Angela PogsonDepartment of Developmental Biology, Stanford University, Stanford, CA 94305, USA.
Tomek SwigutDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford, CA 94305, USA.
Peter ClaesMedical Imaging Research Center, UZ Leuven, Leuven, Belgium; Department of Human Genetics, KU Leuven, Leuven, Belgium; Department of Electrical Engineering, ESAT/PSI, KU Leuven, Leuven, Belgium.
Jussi TaipaleDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden; Department of Biochemistry, University of Cambridge, Cambridge, UK; Applied Tumor Genomics Program, University of Helsinki, Helsinki, Finland.
Joanna WysockaDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford, CA 94305, USA. Electronic address: wysocka@stanford.edu.
Stanford University · USCalifornia Institute for Regenerative Medicine · USKarolinska Institutet · SEUniversitair Ziekenhuis Leuven · BEEuropean Synchrotron Radiation Facility · FRHoward Hughes Medical Institute · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
The Genetic Architecture of Human Facial MorphologyR01DE027023 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CLAES, PETER, SHAFFER, JOHN R · 2017 to 2024
$5.2M
Postgraduate Training Program in Epithelial BiologyT32AR007422 · NIAMS · STANFORD UNIVERSITY · PI PAUL KHAVARI · 1986 to 2026
$5.0M
Uncovering fundamentals of gene regulation by enhancersR35GM131757 · NIGMS · STANFORD UNIVERSITY · PI Joanna Wysocka · 2019 to 2026
$3.1M
Mapping and prediction of quantitative transcription factor dosage effects to understand variation in craniofacial morphology and diseaseK99DE032729 · NIDCR · STANFORD UNIVERSITY · PI NAQVI, SAHIN · 2023 to 2024
$248k
NCI NIH HHS P30 CA124435NIAMS NIH HHS T32 AR007422NIDCR NIH HHS K99 DE032729NIDCR NIH HHS R01 DE027023NIGMS NIH HHS R35 GM131757
6 · The paper itself

Abstract

Transcription factors (TFs) can define distinct cellular identities despite nearly identical DNA-binding specificities. One mechanism for achieving regulatory specificity is DNA-guided TF cooperativity. Although in vitro studies suggest that it may be common, examples of such cooperativity remain scarce in cellular contexts. Here, we demonstrate how "Coordinator," a long DNA motif composed of common motifs bound by many basic helix-loop-helix (bHLH) and homeodomain (HD) TFs, uniquely defines the regulatory regions of embryonic face and limb mesenchyme. Coordinator guides cooperative and selective binding between the bHLH family mesenchymal regulator TWIST1 and a collective of HD factors associated with regional identities in the face and limb. TWIST1 is required for HD binding and open chromatin at Coordinator sites, whereas HD factors stabilize TWIST1 occupancy at Coordinator and titrate it away from HD-independent sites. This cooperativity results in the shared regulation of genes involved in cell-type and positional identities and ultimately shapes facial morphology and evolution.

Indexed as

DNA-Binding ProteinsEmbryonic DevelopmentTranscription FactorsAnimalsBasic Helix-Loop-Helix ProteinsBinding SitesDNAExtremitiesGene Expression RegulationHumansMesodermMiceBasic Helix-Loop-Helix ProteinsDNADNA-Binding ProteinsTranscription FactorsALX factorsbHLHcooperativityCoordinatorfacehomeodomainlimbmesenchymeneural cresttranscription factorTWIST1

Identifiers

PMID38262408
PMCPMC10872279
OpenAlexW4391112869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.